4.2 Article

Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D)

Journal

PRIMARY CARE DIABETES
Volume 4, Issue 4, Pages 231-239

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.pcd.2010.05.005

Keywords

FINDRISC; High-risk strategy; Screening; Metabolic syndrome; Type 2 diabetes; Impaired fasting glucose; Impaired glucose tolerance; Cardiovascular disease; Framingham risk engine; SCORE; Primary health care

Funding

  1. Pirkanmaa, Southern Ostrobothnia, North Ostrobothnia
  2. Central Finland and Northern Savo
  3. Finnish National Public Health Institute
  4. Finnish Diabetes Association
  5. Ministry of Social Affairs and Health in Finland
  6. Finland's Slottery Machine Association
  7. Academy of Finland [129293]
  8. Commission of the European Communities
  9. Directorate C-Public Health [2004310]
  10. Academy of Finland (AKA) [129293, 129293] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Aims: To study screening of high-risk individuals as part of a national diabetes prevention programme in primary health care settings in Finland between 2003 and 2007, and evaluate the cardiometabolic risk profile of persons identified for intervention. Methods: High-risk individuals were identified by the Finnish Diabetes Risk Score (FINDRISC), history of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), cardiovascular disease (CVD), or gestational diabetes. Participants subsequently underwent an oral glucose tolerance test. CVD morbidity risk was estimated by the Framingham Study Risk Equation and CVD mortality risk by the Systematic Coronary Risk Evaluation Formula (SCORE). Results: A high-risk cohort of 10,149 (of whom 30.3% men) was identified (mean age 54.7 for men, 53.0 for women). Altogether 18.8% of men and 11.5% of women had screen-detected diabetes. In total 68.1% of men and 49.4% of women had abnormal glucose tolerance (IFG, IGT or screen-detected diabetes). Furthermore, 43.2% and 41.5% of men, and 13.3% and 11.3% of women, respectively, had a high predicted risk of CVD morbidity or mortality. Conclusion: Prevalence of dysglycemia including undiagnosed diabetes and the predicted risk for CVD was alarmly high in the identified high-risk cohort, particularly in men. (C) 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available